Smith, A. D., Muir, A. J., Heneghan, M. A., Gentile, J. W., & Rockey, D. C. (2004). WHAT IS THE COURSE OF PATIENTS UNDERGOING ANTI-VIRAL THERAPY FOR RECURRENT HEPATITIS C VIRUS LIVER DISEASE? In American Journal of Gastroenterology (Vol. 99, pp. S85–S85). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/00000434-200410001-00258

Smith, Alastair D., Andrew J. Muir, Michael A. Heneghan, Judith W. Gentile, and Don C. Rockey. “WHAT IS THE COURSE OF PATIENTS UNDERGOING ANTI-VIRAL THERAPY FOR RECURRENT HEPATITIS C VIRUS LIVER DISEASE?” In American Journal of Gastroenterology, 99:S85–S85. Ovid Technologies (Wolters Kluwer Health), 2004. https://doi.org/10.14309/00000434-200410001-00258.

Smith AD, Muir AJ, Heneghan MA, Gentile JW, Rockey DC. WHAT IS THE COURSE OF PATIENTS UNDERGOING ANTI-VIRAL THERAPY FOR RECURRENT HEPATITIS C VIRUS LIVER DISEASE? In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2004. p. S85–S85.

Smith, Alastair D., et al. “WHAT IS THE COURSE OF PATIENTS UNDERGOING ANTI-VIRAL THERAPY FOR RECURRENT HEPATITIS C VIRUS LIVER DISEASE?” American Journal of Gastroenterology, vol. 99, Ovid Technologies (Wolters Kluwer Health), 2004, pp. S85–S85. Crossref, doi:10.14309/00000434-200410001-00258.

Smith AD, Muir AJ, Heneghan MA, Gentile JW, Rockey DC. WHAT IS THE COURSE OF PATIENTS UNDERGOING ANTI-VIRAL THERAPY FOR RECURRENT HEPATITIS C VIRUS LIVER DISEASE? American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2004. p. S85–S85.